Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Feasibility Study of Alendronate as Treatment for Osteonecrosis in Adults With Sickle Cell Disease

NCT06016634 is registered in ClinicalTrials.gov with University of California, Davis as lead sponsor.

NCT NCT06016634
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06016634 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Feasibility Study of Alendronate as Treatment for Osteonecrosis in Adults With Sickle Cell Disease
Lead sponsor
University of California, Davis
Phase
Phase 2
Overall status
Recruiting
Start date
March 9, 2026
Completion date
December 31, 2027
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

avascular necrosis, ischemic necrosis, osteonecrosis, sickle cell anemia, sickle cell disease